Cited by 129Vaccine Coverage and HesitancyGlobal Maternal and Child HealthImmune responses and vaccinations

Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries

Open access
Cata-Preta, Bianca O., Santos, Thiago M., Mengistu, Tewodaj, Hogan, Daniel R., Barros, Aluisio J.D., Victora, Cesar G.·2021·Vaccine

Abstract

INTRODUCTION: Zero-dose prevalence refers to children who failed to receive any routine vaccination. Little is known about the "immunisation cascade" in low- and middle-income countries (LMICs), defined as how children move from zero dose to full immunisation. METHODS: Using data from national surveys carried out in 92 LMICs since 2010 and focusing on the four basic vaccines delivered in infancy (BCG, polio, DPT and MCV), we describe zero-dose prevalence and the immunisation cascade in children aged 12 to 23 months. We also describe the most frequent combinations of vaccines (or co-coverage) among children who are partially immunized. Analyses are stratified by country income groups, household wealth quintiles derived from asset indices, sex of the child and area of residence. Results were pooled across countries using child populations as weights. RESULTS: In the 92 countries, 7.7% were in the zero-dose group, and 3.3%, 3.4% and 14.6% received one, two or three vaccines, respectively; 70.9% received the four types and 59.9% of the total were fully immunised with all doses of the four vaccines. Three quarters (76.8%) of children who received the first vaccine received all four types. Among children with a single vaccine, polio was the most common in low- and lower-middle income countries, and BCG in upper-middle income countries. There were sharp inequalities according to household wealth, with zero-dose prevalence ranging from 12.5% in the poorest to 3.4% in the wealthiest quintile across all countries. The cascades were similar for boys and girls. In terms of dropout, 4% of children receiving BCG did not receive DPT1, 14% receiving DPT1 did not receive DPT3, and 9% receiving DPT3 did not progress to receive MCV. INTERPRETATION: Focusing on zero-dose children is particularly important because those who are reached with the first vaccine are highly likely to also receive remaining vaccines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2021.02.072

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cata-Preta, B. O., Santos, T. M., Mengistu, T., Hogan, D. R., Barros, A. J. D., & Victora, C. G.
Corresponding author
Cata-Preta, Bianca O.
Venue
Vaccine
Publisher
Elsevier BV
Published
2021-07
Volume
39
Issue
32
Pages
4564-4570
ISSN
0264-410X (ISSN-L)
OpenAlex
W3137868160
Cited by
129
References
1
Citations by year
2026: 24 · 2025: 26 · 2024: 25 · 2023: 26 · 2022: 18 · 2021: 10
FWCI
10.91
Type
journal article
Language
en
Open access
Locations
  • Vaccine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (OPP1199234, 101815/Z/13/Z)
  • Bill and Melinda Gates Foundation (OPP1199234, 101815/Z/13/Z)
  • GAVI Alliance (OPP1199234, 101815/Z/13/Z)
  • Wellcome Trust (OPP1199234, 101815/Z/13/Z)
Topics
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
zero-dose children, routine childhood immunization, vaccination coverage, BCG vaccine, polio vaccine, DTP vaccine, household wealth inequality, low- and middle-income countries, infant immunization
MeSH terms
Child, Developing Countries, Female, Humans, Immunization, Infant, Male, Vaccination, Vaccines, Immunization Programs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review